Researchers

HAYASHI Hidetoshi

Faculty	Department of Medicine / Graduate School of Medical Sciences
Researchmap	https://researchmap.jp/hayashi_h

Apr. 2023 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology Professor
Apr. 2022 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology 特命准教授
Apr. 2020 - Mar. 2022 , 近畿大学医学部内科学腫瘍内科講師
Oct. 2015 - Mar. 2020 , Kindai university hospital Department of Medical Oncology Lecturer
Apr. 2015 - Sep. 2015 , Kindai university hospital Department of Medical Oncology Assistant professor
Apr. 2013 - Mar. 2015 , Kishiwada City Hospital Department of Medical Oncology Director
Apr. 2009 - Mar. 2013 , Kindai university hospital Department of Medical Oncology assistant professor
Apr. 2006 - Mar. 2009 , Kurashiki Central Hospital Respiratory Medicine Medical Staff
Apr. 2003 - Mar. 2006 , Sumitomo Hospital General Medicine Resident

Cancer of Unknown Primary, Lung Cancer, Gene analysis, medical oncology, immune checkpoint inhibitor

Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
Masayuki Miyata; Hidetoshi Hayashi
Respiratory Investigation Jul. 2025
Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset
Byoung Chul Cho; Hidetoshi Hayashi; Jong-Seok Lee; Se-Hoon Lee; Pongwut Danchaivijitr; Ying Cheng; Baogang Liu; Adlinda Alip; Hailin Xiong; Soon Hin How; Gee-Chen Chang; James Chih-Hsin Yang; Hiroshige Yoshioka; Mehmet Ali Nahit Şendur; Kumar Prabhash; Koichi Azuma; Yun-Gyoo Lee; Chien-Chung Lin; Shingo Matsumoto; Patrapim Sunpaweravong; Yichuan Xia; Melissa Martinez; Joshua M. Bauml; Seema Sethi; Shun Lu
Lung Cancer Jun. 2025
Going forward in pleural mesothelioma: time for a shift from a single-entity treatment approach
H. Hayashi
Annals of Oncology May. 2025

Prognostic impact of EMT-related genes on post-operative prognosis in hepatocellular carcinoma. , 永井知行; 荒尾徳三; 松本和子; 藤田至彦; 林秀敏; 木村英晴; 萩原智; 櫻井俊治; 上嶋一臣; 土師誠二; 工藤正俊; 西尾和人 , AACR 103rd Annual Meeting 2011 , Mar. 2012
進行肺腺癌を対象としたゲフィチニブ／S-1併用療法第１層臨床試験 , 清田秀美; 岡本勇; 田中薫; 林秀敏; 寺嶋応顕; 東公一; 武田真幸; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第51回日本肺癌学会総会 , Nov. 2010
進行肺腺癌を対象としたゲフェチニブ／S-1 併用療法第１相臨床試験 , 清田秀美; 岡本勇; 谷﨑潤子; 文田壮一; 岡本邦男; 牧村ちひろ; 竹澤健; 田中薫; 林秀敏; 岡本渉; 寺嶋応顕; 東公一; 金田裕靖; 武田真幸; 上田眞也; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第92回日本肺癌学会関西支部会 , Jul. 2010

Drug Therapy Based on Cancer Genome Profiling (CGP, Comprehensive Genomic Profiling) in Lung Cancer , 川中雄介; 米阪仁雄; 米阪仁雄; 稲垣千昌; 稲垣千昌; 高濱隆幸; 高濱隆幸; 白石直樹; 坂井和子; 西尾和人; 中川和彦; 林秀敏 , 日本がん分子標的治療学会学術集会プログラム・抄録集 , 28th , 2024
Classification of tissue origin of cancer by methylation profiling , 坂井和子; デベラスコマルコ; 三谷誠一郎; 倉由吏恵; 源周治; 波江野高大; 林秀敏; 林秀敏; 西尾和人; 西尾和人 , 日本癌学会学術総会抄録集(Web) , 83rd , 2024
Current Status and Issues of “imNET“ Activities of the Immune-Related Adverse Events Management Team in Kindai Hospital , 高濱隆幸; 磯本晃佑; 鈴木慎一郎; 渡邉諭美; 金村宙昌; 稲垣千晶; 三谷誠一郎; 谷崎潤子; 吉田健史; 田中薫; 川上尚人; 岩朝勤; 米阪仁雄; 藤原季美子; 萩原智; 西山理; 桑原基; 竹久志穂; 高橋直美; 林秀敏 , 日本臨床腫瘍学会学術集会(CD-ROM) , 21st , 2024

免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均
免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均 , 特許第7251738号

Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model for estimating the primary organ of cancer of unknown primary by methylation analysis of circulating tumor DNA , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model to estimate the primary organ of cancer of unknown primary , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors , Kindai University